Business News • PR NewsWire • Sangamo BioSciences Announces Presentation of Groundbreaking Clinical Data From ZFN Therapeutic for HIV/AIDS at ICAAC 2011

Sangamo BioSciences Announces Presentation of Groundbreaking Clinical Data From ZFN Therapeutic for HIV/AIDS at ICAAC 2011

Sangamo BioSciences Announces Presentation of Groundbreaking Clinical Data From ZFN Therapeutic for HIV/AIDS at ICAAC 2011

RICHMOND, Calif., Sept. 18, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach for the treatment of HIV/AIDS, were discussed in two presentations at the 51st Interscience...

View More : http://www.prnewswire.com/news-releases/sangamo-biosciences-announces-presentation-of-groundbreaking-clinical-data-from-...

Releted News by prnewswire

OFS TruePhase® IPLM Inline Polarimeter Powers Up New Ridge Technologies Test and Measurement Platform

Rentrak Announces Official Box Office Numbers for Weekend of September 16, 2011

Already Over 350,000 Visitors at the IAA

INOVA Announces Five New Land Seismic Products